SLC9A6 and metabolic dysfunction-associated steatotic liver disease: Furthermore, liver tissues from patients with NAFLD also accumulate SLC9A6‐126aa derived from circ‐SLC9A6, suggesting a potential pathogenic role for this process in human lipid metabolism‐related disorders.34